5.360USD+638.19%Mkt Cap: 418.66M USDP/E: —Last update: 2026-06-01
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap418.66M USD
Enterprise Value-1.19M USD
Revenue (TTM)20.34M USD
Gross Profit20.34M USD
Net Income (TTM)-8.61M USD
Revenue/Share0.4040 USD
Last Price5.360 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees18
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS8112922005
Valuation
P/E (Trailing)—
P/E (Forward)-2.24
PEG—
EV/EBITDA—
EV/Revenue-0.06
P/S0.34
P/B1.06
EPS (TTM)-0.48
EPS (Forward)-0.32
52W Range
0.565095% of range5.620
52W High5.620 USD
52W Low0.5650 USD
Profitability
Gross Margin100.00%
Oper. Margin-119.95%
EBITDA Margin0.00%
Profit Margin-41.79%
ROE-17.44%
ROA-14.58%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.28M USD
CapEx (TTM)—
FCF Margin13.03%
FCF Yield0.63%
Net Debt-57.20M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.04
Current Ratio3.94
Quick Ratio3.73
Book Value/Sh0.6660 USD
Cash/Share0.7460 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 17, 2020
Splits
Last Split1:10
Split DateJul 17, 2020
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)4.193 USD
Target Range3.000 USD – 5.580 USD
# Analysts3
Ownership
Shares Out.79.44M
Float57.60M
Insiders1.96%
Institutions42.33%
Short Interest
Short Ratio5.9d
Short % Float2.92%
Short % Out.2.86%
Shares Short2.27M
Short (prev mo.)1.17M
Technical
SMA 500.8995 (+495.9%)
SMA 2000.7987 (+571.1%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)377.30K
Avg Vol (10d)492.95K
Technical Indicators
RSI (14)39.6
MACD-0.0618
MACD Signal-0.0610
MACD Hist.-0.0008
BB Upper1.033 USD
BB Middle0.7993 USD
BB Lower0.5661 USD
BB Width58.36%
ATR (14)0.0636 USD
Vol Ratio (20d)0.60x